This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Morningstar analysts do not currently cover CRPC, but with our powerful screener, you can find stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
Better mCRPC Survival with Docetaxel Followed by Abiraterone An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results